X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-08-12 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $601.49 | -11,824 | 5,336,997 | 0% | -$7,111,969 | |||||
2026-08-12 | INCY | Incyte Corp | Cagnoni Pablo J | Pres, Global Head of R, D | S - Sale | $120.04 | -10,803 | 194,001 | -5% | -$1,296,792 | ||||||
| D | 2026-08-11 | CRL | Charles River Laboratories International, Inc. | Girshick Birgit | CEO | S - Sale+OE | $279.90 | -6,500 | 79,816 | -8% | -$1,819,350 | |||||
| D | 2026-08-11 | CRL | Charles River Laboratories International, Inc. | Parisotto Shannon M | CEVP, Disc, Safety Assessment | S - Sale+OE | $279.66 | -3,714 | 42,997 | -8% | -$1,038,657 | |||||
2026-08-11 | MEDP | Medpace Holdings, Inc. | McCarthy Cornelius P. III | Dir | S - Sale | $605.37 | -1,140 | 12,275 | -8% | -$690,122 | ||||||
| D | 2026-08-11 | ICLR | Icon Plc | Whitaker Anne Clem | Dir | S - Sale+OE | $164.29 | -841 | 891 | -49% | -$138,168 | |||||
| D | 2026-08-11 | ICLR | Icon Plc | O'Neill Julie | Dir | S - Sale+OE | $164.29 | -915 | 3,515 | -21% | -$150,326 | |||||
| D | 2026-08-11 | ICLR | Icon Plc | Murray Ciaran | Dir | S - Sale+OE | $164.29 | -2,677 | 20,452 | -12% | -$439,803 | |||||
| D | 2026-08-11 | ICLR | Icon Plc | Murphy Ronan Martin | Dir | S - Sale+OE | $164.29 | -841 | 3,847 | -18% | -$138,168 | |||||
| D | 2026-08-11 | ICLR | Icon Plc | McCague Eugene Pacelli | Dir | S - Sale+OE | $164.29 | -841 | 3,811 | -18% | -$138,168 | |||||
| D | 2026-08-11 | ICLR | Icon Plc | Grais Linda | Dir | S - Sale+OE | $164.29 | -841 | 6,162 | -12% | -$138,169 | |||||
| D | 2026-08-11 | ICLR | Icon Plc | Climax John Dr | Dir | S - Sale+OE | $164.29 | -841 | 2,087 | -29% | -$138,168 | |||||
| D | 2026-08-11 | ICLR | Icon Plc | Clerkin Nigel Bernard John | CFO | S - Sale+OE | $164.29 | -2,267 | 5,881 | -28% | -$372,445 | |||||
| M | 2026-08-10 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $604.25 | -23,144 | 5,348,821 | 0% | -$13,984,854 | |||||
| D | 2026-08-10 | CRL | Charles River Laboratories International, Inc. | Foster James C | Dir | S - Sale+OE | $275.00 | -28,733 | 233,410 | -11% | -$7,901,575 | |||||
| D | 2026-08-10 | ICLR | Icon Plc | Balfe Barry Edward | CEO | S - Sale+OE | $164.07 | -382 | 4,804 | -7% | -$62,676 | |||||
| D | 2026-08-07 | MEDP | Medpace Holdings, Inc. | McCarthy Cornelius P. III | Dir | S - Sale+OE | $585.07 | -795 | 13,415 | -6% | -$465,131 | |||||
| D | 2026-08-06 | CRL | Charles River Laboratories International, Inc. | Knell Michael Gunnar | SVP, Finance, CAO | S - Sale+OE | $260.38 | -6,645 | 11,852 | -36% | -$1,730,250 | |||||
| D | 2026-08-06 | CRL | Charles River Laboratories International, Inc. | Creamer Victoria L | EVP, Chief People Officer | S - Sale+OE | $259.16 | -4,179 | 30,051 | -12% | -$1,083,030 | |||||
2026-07-30 | ONMD | Onemednet Corp | Kosasa Thomas | Dir, 10% | P - Purchase | $0.69 | +1,449,275 | 18,538,150 | +8% | +$1,000,000 | ||||||
2026-08-05 | INCY | Incyte Corp | Cagnoni Pablo J | Pres, Global Head of R, D | S - Sale | $122.69 | -10,640 | 204,804 | -5% | -$1,305,422 | ||||||
| D | 2026-08-05 | INCY | Incyte Corp | Mayes Patrick A | EVP, Chief Scientific Officer | S - Sale+OE | $123.99 | -2,207 | 61,441 | -3% | -$273,646 | |||||
2026-08-05 | CRL | Charles River Laboratories International, Inc. | Parisotto Shannon M | CEVP, Disc, Safety Assessment | S - Sale | $263.00 | -5,046 | 42,997 | -11% | -$1,327,098 | ||||||
2026-08-03 | IQV | Iqvia Holdings Inc. | Staub W Richard | See Remarks | S - Sale | $232.68 | -5,500 | 13,312 | -29% | -$1,279,740 | ||||||
2026-07-31 | IQV | Iqvia Holdings Inc. | Patel Bhavik | See Remarks | S - Sale | $235.27 | -1,855 | 1,348 | -58% | -$436,426 | ||||||
2026-07-31 | INCY | Incyte Corp | Cagnoni Pablo J | Pres, Global Head of R, D | S - Sale | $119.70 | -15,888 | 215,444 | -7% | -$1,901,794 | ||||||
| DM | 2026-07-31 | INCY | Incyte Corp | Mayes Patrick A | EVP, Chief Scientific Officer | S - Sale+OE | $119.58 | -47,954 | 61,441 | -44% | -$5,734,376 | |||||
2026-07-29 | IQV | Iqvia Holdings Inc. | Sherbet Eric | See Remarks | S - Sale | $249.16 | -5,000 | 20,999 | -19% | -$1,245,800 | ||||||
2026-07-29 | IQV | Iqvia Holdings Inc. | Cherofsky Keriann | See Remarks | S - Sale | $245.21 | -558 | 2,989 | -16% | -$136,827 | ||||||
| D | 2026-07-29 | IQV | Iqvia Holdings Inc. | Bousbib Ari | See Remarks | S - Sale+OE | $245.51 | -106,279 | 1,379,243 | -7% | -$26,092,072 | |||||
| M | 2026-07-27 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Pres, CEO, 10% | S - Sale | $600.44 | -7,238 | 5,371,965 | 0% | -$4,346,004 | |||||
2026-07-28 | MEDP | Medpace Holdings, Inc. | Burwig Susan E | EVP, Operations | S - Sale | $600.00 | -7,500 | 62,984 | -11% | -$4,500,000 | ||||||
| D | 2026-07-16 | INCY | Incyte Corp | Stein Steven H | CMO, Head of Late-Stage Dev. | S - Sale+OE | $114.73 | -1,877 | 30,916 | -6% | -$215,348 | |||||
| D | 2026-07-16 | INCY | Incyte Corp | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | S - Sale+OE | $115.01 | -1,093 | 71,797 | -1% | -$125,706 | |||||
2026-07-15 | INCY | Incyte Corp | Stein Steven H | CMO, Head of Late-Stage Dev. | S - Sale | $113.05 | -28,237 | 22,995 | -55% | -$3,192,193 | ||||||
2026-06-30 | ABSI | Absci Corp | Szela Mary T | Dir | P - Purchase | $11.54 | +12,900 | 21,300 | +154% | +$148,866 | ||||||
2026-06-29 | CRL | Charles River Laboratories International, Inc. | Foster James C | Dir | S - Sale | $225.00 | -75,000 | 233,410 | -24% | -$16,875,000 | ||||||
2026-06-23 | ONMD | Onemednet Corp | Green Aaron | CEO | P - Purchase | $0.57 | +36,650 | 1,896,375 | +2% | +$21,011 | ||||||
2026-06-23 | ONMD | Onemednet Corp | Yu Jeffrey | Chief Medical Officer, 10% | P - Purchase | $0.63 | +158,730 | 10,092,380 | +2% | +$100,000 | ||||||
2026-06-16 | ONMD | Onemednet Corp | Yu Jeffrey | Chief Medical Officer, 10% | P - Purchase | $0.58 | +172,414 | 9,933,650 | +2% | +$100,000 | ||||||
| M | 2026-06-12 | ONMD | Onemednet Corp | Green Aaron | CEO | P - Purchase | $0.55 | +55,622 | 1,859,725 | +3% | +$30,697 | |||||
2026-06-12 | ONMD | Onemednet Corp | Kosasa Thomas | Dir, 10% | P - Purchase | $0.63 | +158,730 | 17,088,874 | +1% | +$100,000 | ||||||
| M | 2026-05-06 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.03 | -111,058 | 30,099,930 | 0% | -$3,468 | |||||
| D | 2026-06-04 | INCY | Incyte Corp | Tray Thomas | Principal Accounting Officer | S - Sale+OE | $100.00 | -2,639 | 21,132 | -11% | -$263,900 | |||||
| D | 2026-05-28 | MEDP | Medpace Holdings, Inc. | Ewald Stephen P | GC, Corp. Secy. | S - Sale+OE | $450.00 | -16,349 | 20,343 | -45% | -$7,357,050 | |||||
2026-05-26 | INCY | Incyte Corp | Tray Thomas | Principal Accounting Officer | S - Sale | $97.35 | -2,051 | 21,132 | -9% | -$199,665 | ||||||
| D | 2026-05-19 | INCY | Incyte Corp | Clancy Paul J | Dir | S - Sale+OE | $94.93 | -15,000 | 23,741 | -39% | -$1,423,950 | |||||
2026-05-18 | ONMD | Onemednet Corp | Kosasa Thomas | Dir, 10% | P - Purchase | $0.93 | +268,817 | 16,930,144 | +2% | +$250,000 | ||||||
2026-05-13 | ABSI | Absci Corp | Pangalos Menelas N | Dir | P - Purchase | $5.36 | +37,453 | 232,308 | +19% | +$200,748 | ||||||
2026-04-01 | ONMD | Onemednet Corp | Yu Jeffrey | Chief Medical Officer, 10% | P - Purchase | $0.83 | +903,614 | 9,761,236 | +10% | +$750,000 | ||||||
| M | 2026-02-06 | ONMD | Onemednet Corp | Kosasa Thomas | Dir, 10% | P - Purchase | $0.86 | +876,136 | 16,661,327 | +6% | +$749,999 | |||||
| D | 2026-04-17 | INCY | Incyte Corp | Cagnoni Pablo J | Pres, Global Head of R, D | S - Sale+OE | $96.50 | -18,667 | 262,692 | -7% | -$1,801,366 | |||||
| D | 2026-04-07 | OABI | Omniab, Inc. | Foehr Matthew W | Pres, CEO | S - Sale+OE | $1.49 | -19,244 | 4,420,492 | 0% | -$28,674 | |||||
| D | 2026-04-07 | OABI | Omniab, Inc. | Gustafson Kurt A | EVP, Finance, CFO | S - Sale+OE | $1.49 | -6,913 | 261,483 | -3% | -$10,300 | |||||
| D | 2026-04-07 | OABI | Omniab, Inc. | Berkman Charles S | GC | S - Sale+OE | $1.49 | -7,157 | 399,085 | -2% | -$10,664 | |||||
| D | 2026-03-17 | MEDP | Medpace Holdings, Inc. | Geiger Jesse J | Pres | S - Sale+OE | $455.30 | -31,707 | 15,000 | -68% | -$14,436,197 | |||||
| D | 2026-03-17 | INCY | Incyte Corp | Cagnoni Pablo J | Pres, R, D | S - Sale+OE | $94.24 | -18,667 | 234,800 | -7% | -$1,759,178 | |||||
2026-03-17 | MXCT | Maxcyte, Inc. | Swirsky Douglas J | CFO | S - Sale | $0.82 | -10,142 | 151,669 | -6% | -$8,266 | ||||||
2026-03-12 | ABSI | Absci Corp | Busch Andreas | Chief Innovation Officer | P - Purchase | $2.29 | +100,000 | 421,446 | +31% | +$229,000 | ||||||
2026-03-03 | CRL | Charles River Laboratories International, Inc. | Laplume Joseph W | EVP, Corp Strategy, Develop | P - Purchase | $174.54 | +25 | 27,448 | 0% | +$4,364 | ||||||
2026-02-27 | ABSI | Absci Corp | Pangalos Menelas N | Dir | P - Purchase | $2.74 | +75,095 | 189,055 | +66% | +$205,760 | ||||||
| M | 2026-01-22 | BUDZ | Weed, Inc. | Breen Nicole M | Secretary, Treasurer, 10% | S - Sale | $0.04 | -240,605 | 30,210,988 | -1% | -$8,462 | |||||
| D | 2026-02-19 | INCY | Incyte Corp | Cagnoni Pablo J | Pres, R, D | S - Sale+OE | $100.91 | -18,668 | 234,800 | -7% | -$1,883,788 | |||||
2026-02-17 | NRC | National Research Corp | Harrison Shane R | EVP, CFO | P - Purchase | $12.27 | +8,000 | 158,729 | +5% | +$98,162 | ||||||
2026-02-17 | NOTV | Inotiv, Inc. | Taylor Beth A. | CFO | S - Sale | $0.29 | -2,888 | 145,480 | -2% | -$846 | ||||||
2026-02-17 | NOTV | Inotiv, Inc. | Sagartz John E | Chief Strategy Officer | S - Sale | $0.29 | -2,119 | 735,697 | 0% | -$616 | ||||||
2026-02-17 | NOTV | Inotiv, Inc. | Leasure Robert Jr. | Pres, CEO | S - Sale | $0.30 | -16,810 | 1,361,215 | -1% | -$4,964 | ||||||
| D | 2026-02-18 | OABI | Omniab, Inc. | Berkman Charles S | GC | S - Sale+OE | $1.71 | -9,673 | 392,700 | -2% | -$16,541 | |||||
| D | 2026-02-18 | OABI | Omniab, Inc. | Gustafson Kurt A | EVP, Finance, CFO | S - Sale+OE | $1.71 | -9,301 | 268,851 | -3% | -$15,905 | |||||
| D | 2026-02-18 | OABI | Omniab, Inc. | Foehr Matthew W | Pres, CEO | S - Sale+OE | $1.71 | -30,843 | 4,403,277 | -1% | -$52,742 | |||||
| D | 2026-02-17 | OABI | Omniab, Inc. | Foehr Matthew W | Pres, CEO | S - Sale+OE | $1.70 | -20,754 | 4,375,787 | 0% | -$35,282 | |||||
| D | 2026-02-17 | OABI | Omniab, Inc. | Gustafson Kurt A | EVP, Finance, CFO | S - Sale+OE | $1.70 | -6,828 | 259,402 | -3% | -$11,608 | |||||
| D | 2026-02-17 | OABI | Omniab, Inc. | Berkman Charles S | GC | S - Sale+OE | $1.70 | -6,990 | 383,623 | -2% | -$11,883 | |||||
2026-02-02 | ABSI | Absci Corp | McClain Sean | CEO | S - Sale | $2.99 | -26,761 | 8,334,567 | 0% | -$80,015 | ||||||
2026-02-02 | ABSI | Absci Corp | Jonasson Zachariah | CFO , CBO | S - Sale | $2.99 | -17,496 | 383,538 | -4% | -$52,313 | ||||||
2026-02-02 | NOTV | Inotiv, Inc. | Leasure Robert Jr. | Pres, CEO | S - Sale | $0.50 | -113,297 | 1,378,025 | -8% | -$57,034 | ||||||
2025-08-22 | CRL | Charles River Laboratories International, Inc. | Laplume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $163.72 | -400 | 23,716 | -2% | -$65,488 | ||||||
2026-01-07 | INCY | Incyte Corp | Issa Mohamed Khairie | EVP, Head of US Oncology | S - Sale | $109.07 | -10,856 | 66,132 | -14% | -$1,184,064 | ||||||
2026-01-05 | INCY | Incyte Corp | Stein Steven H | EVP, Chief Medical Officer | S - Sale | $101.70 | -15,634 | 34,203 | -31% | -$1,589,978 | ||||||
| M | 2025-10-22 | ONMD | Onemednet Corp | Green Aaron | CEO | S - Sale | $1.73 | -126,322 | 1,804,103 | -7% | -$218,625 | |||||
| DM | 2025-12-18 | INCY | Incyte Corp | Tray Thomas | Principal Accounting Officer | S - Sale+OE | $99.69 | -3,374 | 22,973 | -13% | -$336,350 | |||||
| D | 2025-12-18 | IQV | Iqvia Holdings Inc. | Bousbib Ari | See Remarks | S - Sale+OE | $222.43 | -36,564 | 1,350,465 | -3% | -$8,132,931 | |||||
| M | 2025-12-16 | INCY | Incyte Corp | Morrissey Michael James | EVP, Head of Tech. Operations | S - Sale | $97.29 | -58,331 | 27,507 | -68% | -$5,675,002 | |||||
| M | 2025-12-10 | INCY | Incyte Corp | Mayes Patrick A | EVP, Chief Scientific Officer | S - Sale | $95.55 | -5,808 | 60,011 | -9% | -$554,965 | |||||
2025-12-05 | ABSI | Absci Corp | Van Houten Frans | Dir | P - Purchase | $3.72 | +40,000 | 63,320 | +172% | +$148,800 | ||||||
| D | 2025-12-08 | OABI | Omniab, Inc. | Berkman Charles S | GC | S - Sale+OE | $1.96 | -8,044 | 377,071 | -2% | -$15,766 | |||||
| D | 2025-12-08 | OABI | Omniab, Inc. | Gustafson Kurt A | EVP, Finance, CFO | S - Sale+OE | $1.96 | -23,922 | 252,688 | -9% | -$46,887 | |||||
| D | 2025-12-08 | OABI | Omniab, Inc. | Foehr Matthew W | Pres, CEO | S - Sale+OE | $1.96 | -13,666 | 4,360,083 | 0% | -$26,785 | |||||
2025-12-03 | MEDP | Medpace Holdings, Inc. | Troendle August J. | CEO, 10% | S - Sale | $590.69 | -668 | 5,379,203 | 0% | -$394,581 | ||||||
| M | 2025-12-01 | INCY | Incyte Corp | Stein Steven H | EVP, Chief Medical Officer | S - Sale | $102.56 | -22,664 | 63,129 | -26% | -$2,324,438 | |||||
| M | 2025-12-01 | MEDP | Medpace Holdings, Inc. | Troendle August J. | CEO, 10% | S - Sale | $592.70 | -28,876 | 5,379,871 | -1% | -$17,114,847 | |||||
2025-12-01 | NOTV | Inotiv, Inc. | Neff R Matthew | Dir | S - Sale | $0.89 | -2,000 | 151,102 | -1% | -$1,771 | ||||||
| M | 2025-11-26 | MEDP | Medpace Holdings, Inc. | Troendle August J. | CEO, 10% | S - Sale | $603.28 | -56,482 | 5,408,747 | -1% | -$34,074,470 | |||||
| DM | 2025-06-20 | ONMD | Onemednet Corp | Yu Jeffrey | Chief Medical Officer | P - Purchase | $0.48 | +2,010,479 | 8,638,193 | +30% | +$959,586 | |||||
| M | 2024-02-01 | ONMD | Onemednet Corp | Yu Jeffrey | Chief Medical Officer | P - Purchase | $0.94 | +9,540 | 4,075,165 | 0% | +$8,929 | |||||
2023-12-07 | ONMD | Onemednet Corp | Golden Robert Lawrence | CFO | P - Purchase | $1.71 | +300 | 547,905 | 0% | +$513 | ||||||
| DM | 2025-04-21 | ONMD | Onemednet Corp | Kosasa Thomas | Dir | P - Purchase | $0.56 | +1,879,871 | 15,785,191 | +14% | +$1,049,475 | |||||
| M | 2024-02-16 | ONMD | Onemednet Corp | Casaburi Eric | Dir | P - Purchase | $1.92 | +20,475 | 110,475 | +23% | +$39,262 | |||||
| M | 2023-12-08 | ONMD | Onemednet Corp | Yu Jeffrey | Chief Medical Officer | P - Purchase | $0.76 | +22,762 | 3,834,856 | +1% | +$17,192 | |||||
| M | 2025-11-24 | MEDP | Medpace Holdings, Inc. | Troendle August J. | CEO, 10% | S - Sale | $611.02 | -101,417 | 5,465,229 | -2% | -$61,967,338 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |